For EGFR Research, New Targeted Drugs Mean New Questions

In this: publication
By this: publisher
In this Subject: Oncology
By this author: Vastag, Brian

Author: Vastag, Brian

Source: Journal of the National Cancer Institute, Volume 97, Number 9, 4 May 2005 , pp. 628-630(3)

Purchase options

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$38.05 plus tax Refund Policy

More about this publication?

JNCI - Journal of the National Cancer Institute publishes peer-reviewed original research from around the world and is internationally acclaimed as the source for the most up-to-date news and information from the rapidly changing fields of cancer research and treatment. For the past several years, the JNCI has been ranked as the most-cited original-research cancer journal by the Institute of Scientific Information in its annual Journal Citation Reports. The Journal of the National Cancer Institute's impact factor for 2005, as reported in 2006, was 15.171.

More like this?